Image

A Study of TQB2930 for Injection Monotherapy or Combination Chemotherapy in Patients With Recurrent/Metastatic Breast Cancer

Recruiting
18-75 years
Both
Phase 1/2
  • Simplified (AI rewritten)
  • Technical (Original)

A Study of TQB2930 is aimed at finding a safe and effective dose of an investigational drug for patients with a type of breast cancer that has returned or spread. This study has two phases. In Phase Ib, researchers identify the best dose of the drug to use. Then, in Phase II, they test the drug's effects when combined with another cancer drug, called docetaxel. The study looks at how well the combination works and its safety.

To join, you need to be 18-75 years old and have a good general health status. You must have specific types of breast cancer and meet certain health criteria. You cannot join if you have other serious health issues or are taking certain medicines.

  • The study involves multiple visits to monitor your health and the effects of the treatment.
  • Participants must agree to use birth control during and after the study for safety reasons.
  • No other cancer treatments are allowed during the study period.

This research helps scientists learn about new ways to treat breast cancer. Participants contribute to important medical advances while receiving close health monitoring. 🧬💊

Print
Study details
    Metastatic Breast Cancer
    Recurrent Breast Cancer

NCT06202261

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

24 January 2024

Contact a study center
Not finding the right Trial?

You can also call our Patient navigators who can help you to find the right trial.

Call now
Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.